Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ)
CNY 6.11
(-0.49%)
CNY 6.11
(-0.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.04 Billion | 795.93 Million | 714.74 Million | 738.71 Million | 628.34 Million | 622.09 Million |
| Cost of Revenue | 590.56 Million | 541.13 Million | 421.91 Million | 379.01 Million | 324.27 Million | 309.73 Million |
| Gross Profit | 454.86 Million | 254.79 Million | 292.83 Million | 359.7 Million | 304.06 Million | 312.35 Million |
| Operating Expenses | 421.04 Million | 345.3 Million | 390.48 Million | 318.43 Million | 245.95 Million | 252.78 Million |
| Selling, General and Administrative Expenses | 190.36 Million | 156.88 Million | 205.86 Million | 179.58 Million | 146.25 Million | 148.8 Million |
| Research and Development Expenses | 69.2 Million | 64.78 Million | 81.48 Million | 48.17 Million | 46.57 Million | 53.45 Million |
| Other Expenses | - | -6.14 Million | -1.87 Million | -2.79 Million | -1.53 Million | -659.26 Thousand |
| Cost and Expenses | 1.01 Billion | 886.44 Million | 812.39 Million | 697.44 Million | 570.23 Million | 562.51 Million |
| Operating Income | 58.96 Million | -127.63 Million | -502.3 Million | 3.46 Million | 11.08 Million | 107.63 Million |
| Interest Expense | 27.62 Million | 42.25 Million | 45.05 Million | 35.43 Million | 43.42 Million | 34.01 Million |
| Income Tax Expense | 18.04 Million | 4.14 Million | 1.6 Million | 8.13 Million | 7.6 Million | 29.46 Million |
| Earnings before Tax | 33.72 Million | -133.78 Million | -504.18 Million | 585 Thousand | 9.63 Million | 106.97 Million |
| Net Income | -24.92 Million | -78.32 Million | -322.17 Million | 7.5 Million | 2.54 Million | 69.43 Million |
| Earnings Per Share Basic | -0.03 | -0.10 | -0.39 | 0.01 | 0.00 | 0.08 |
| Earnings Per Share Diluted | -0.03 | -0.10 | -0.39 | 0.01 | 0.00 | 0.08 |
| Weighted Average Shares Outstanding | 817.35 Million | 816.9 Million | 816.9 Million | 816.9 Million | 816.9 Million | 818.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 817.35 Million | 816.9 Million | 816.9 Million | 816.9 Million | 816.9 Million | 818.84 Million |
| Gross Margin | 0.44 | 0.32 | 0.41 | 0.49 | 0.48 | 0.50 |
| EBIT Margin | 0.18 | 0.01 | 0.02 | 0.18 | 0.21 | 0.77 |
| Profit Margin | -0.02 | -0.10 | -0.45 | 0.01 | 0.00 | 0.11 |
| EBITDA | 185.8 Million | 28.81 Million | -344.36 Million | 136.24 Million | 137.1 Million | 219.55 Million |
| Earnings Before Tax Margin | 0.06 | -0.16 | -0.70 | 0.00 | 0.02 | 0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 159.17 Million | 224.83 Million | 262.05 Million | 1.04 Billion | 239.32 Million | 279.19 Million |
| Cost of Revenue | 80.61 Million | 105.99 Million | 132.21 Million | 590.56 Million | 128.13 Million | 143.91 Million |
| Gross Profit | 78.56 Million | 118.84 Million | 129.83 Million | 454.86 Million | 111.19 Million | 135.27 Million |
| Operating Expenses | 93.92 Million | 89.65 Million | 73.1 Million | 385.43 Million | 98.63 Million | 109.08 Million |
| Selling, General and Administrative Expenses | 166.51 Million | 19.05 Million | 59.26 Million | - | -37.59 Million | 131.56 Million |
| Research and Development Expenses | 12.62 Million | 16.1 Million | 14.55 Million | - | 15.55 Million | 24.13 Million |
| Other Expenses | -85.2 Million | -1.8 Million | -57.53 Thousand | -85.69 Thousand | 552.23 Thousand | 3200.01 |
| Cost and Expenses | 174.54 Million | 195.65 Million | 205.31 Million | 975.99 Million | 226.76 Million | 253 Million |
| Operating Income | -26.25 Million | 21.58 Million | 49.88 Million | 33.81 Million | 3.49 Million | 15.74 Million |
| Interest Expense | 7.28 Million | 4.77 Million | 5.57 Million | 27.62 Million | 11.63 Million | 4.19 Million |
| Income Tax Expense | 3.08 Million | 5.86 Million | 7.8 Million | 18.04 Million | 2.78 Million | 4.59 Million |
| Earnings before Tax | -8.27 Million | 20.2 Million | 49.83 Million | 33.72 Million | 4.04 Million | 15.74 Million |
| Net Income | -3.91 Million | 7.77 Million | 19.86 Million | -24.92 Million | -39.06 Million | 8.21 Million |
| Earnings Per Share Basic | -0.00 | 0.01 | 0.02 | - | -0.05 | 0.01 |
| Earnings Per Share Diluted | -0.00 | 0.01 | 0.02 | - | -0.05 | 0.01 |
| Weighted Average Shares Outstanding | 816.9 Million | 817.43 Million | 817.43 Million | 817.35 Million | 817.9 Million | 816.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 816.9 Million | 817.43 Million | 817.43 Million | 817.35 Million | 817.89 Million | 816.9 Million |
| Gross Margin | 0.49 | 0.53 | 0.50 | 0.44 | 0.46 | 0.48 |
| EBIT Margin | -0.01 | 0.12 | 0.21 | - | 0.07 | 0.09 |
| Profit Margin | -0.02 | 0.03 | 0.08 | -0.02 | -0.16 | 0.03 |
| EBITDA | -995.18 Thousand | 27.1 Million | 55.98 Million | - | 17.13 Million | 24.28 Million |
| Earnings Before Tax Margin | -0.16 | 0.10 | 0.19 | 0.03 | 0.01 | 0.06 |
XFAB
5928
5922
CLBR
5440
CIBUS